The GLP-1 medication is now available via injection and pill.

The target action date for orforglipron is now April 10.

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

Novo Nordisk's weight loss pill could give the company's numbers a big boost this year.

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

Novo Nordisk’s Wegovy weight loss pill hit U.S. pharmacies this week and could change obesity care. Here’s how the Wegovy pill works, who qualifies, how to take it, side effects, cost, and what this ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the growth of the revolutionary drugs. The drug, a ...

Add Yahoo as a preferred source to see more of our stories on Google. Image of 1.5 mg starter dose of Wegovy® pill (PRNewsfoto/NOVO NORDISK INC.) Novo Nordisk has launched the first once-daily GLP-1 ...

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The launch this week of an oral pill version of Wegovy ...

Some tout a daily semaglutide pill as a game-changer for weight-loss treatment. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo ...